Aethlon Medical has 1,604,095 common shares outstanding after recent exercises removed every pre-funded Warrant that had remained unexercised. For investors, the update establishes the company’s common-stock count at the close of Business on August 28 and confirms that no pre-funded warrants remain outstanding.
Key Highlights
- Every previously unexercised pre-funded warrant has now been exercised.
- Aethlon Medical measured its common-stock total at the August 28 close of business.
- Chief Executive Officer and Chief Financial Officer James B. Frakes signed the update on August 31, 2026.
AETHLON MEDICAL INC (NASDAQ: AEMD) had 1,604,095 shares of common stock outstanding at the close of business on August 28, following recent exercises of pre-funded warrants. Every pre-funded warrant that had previously remained outstanding was exercised.
All Pre-Funded Warrants Exercised
The updated share count covers Aethlon Medical’s common stock. The company tied the figure to the end of business on August 28, 2026. The exercises completed the conversion of all previously outstanding pre-funded warrants.
James B. Frakes signed the update for Aethlon Medical on August 31, 2026, in his roles as chief executive officer and chief financial officer.
FAQs
Q: How many Aethlon Medical shares are outstanding?
A: Aethlon Medical reported 1,604,095 shares of common stock outstanding as of the close of business on August 28, 2026.
Q: What happened to Aethlon Medical’s pre-funded warrants?
A: Recent exercises resulted in every previously outstanding pre-funded warrant being exercised. Aethlon Medical therefore reported that all such warrants had been exercised.
Q: When was Aethlon Medical’s share count measured?
A: The common-stock total was measured at the close of business on August 28, 2026. James B. Frakes signed the update on August 31, 2026.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.